The program can collectively award a total of up to US$1 million in grants. The research project duration can extend over two years.
The PHAB Awards aim to support clinical research in pulmonary hypertension (PH) with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). All investigators, clinicians, and allied HCPs working within PH in the United States today may apply. The objectives of the program are to:
- Support continued advancement in PH science and care
- Contribute to the growing body of PH research seeking to improve patient outcomes